{"id":385084,"date":"2024-10-20T03:29:00","date_gmt":"2024-10-20T03:29:00","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-166722021\/"},"modified":"2024-10-26T06:18:52","modified_gmt":"2024-10-26T06:18:52","slug":"bs-en-iso-166722021","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-166722021\/","title":{"rendered":"BS EN ISO 16672:2021"},"content":{"rendered":"
This document applies to ocular endotamponades (OE), a group of non-solid surgically invasive medical devices introduced into the vitreous cavity of the eye to flatten and position a detached retina onto the retinal pigment epithelium (RPE), or to tamponade the retina.<\/p>\n
With regard to the safety and efficacy of OE, this document specifies requirements for their intended performance, design attributes, pre-clinical and clinical evaluation, sterilization, product packaging, product labelling and the information supplied by the manufacturer.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | National foreword <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | European foreword <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 4 Intended performance 5 Design attributes 5.1 General 5.2 Chemical description and contaminants <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 5.3 Density 5.4 Gaseous expansion 5.5 Interfacial tension 5.6 Kinematic viscosity 5.7 Dynamic viscosity 5.8 Molecular mass distribution <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 5.9 Particulates 5.10 Refractive index 5.11 Spectral transmittance 5.12 Surface tension 5.13 Vapour pressure 6 Design evaluation 6.1 General <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 6.2 Evaluation of biological safety 6.2.1 General 6.2.2 Bacterial endotoxins test 6.2.3 Intraocular implantation test 6.2.4 Ethylene oxide <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 6.3 Clinical investigation 7 Sterilization 8 Product stability 9 Integrity and performance of the delivery system <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 10 Packaging 10.1 Protection from damage during storage and transport 10.2 Maintenance of sterility in transit 11 Information supplied by the manufacturer <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | Annex A (normative) Intraocular implantation test <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | Annex B (informative) Clinical investigation <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | Annex C (informative) Method for quantifying incompletely fluorinated contaminants in perfluorocarbon liquids <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Ophthalmic implants. Ocular endotamponades<\/b><\/p>\n |